The Mucosal Adjuvanticity of Cholera Toxin Involves Enhancement of Costimulatory Activity by Selective Up-Regulation of B7.2 Expression

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5301-5308

  Cong, Yingzi ^a   Weaver, Casey T ^b   Elson, Charles O ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; CHOLERA TOXIN; IMMUNOLOGICAL ADJUVANT; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; BONE MARROW CELL; C3H MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; FEMALE; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; MUCOSAL IMMUNITY; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CHOLERA TOXIN; FEMALE; IMMUNITY, MUCOSAL; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; UP-REGULATION;

EID: 0031296660     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Dresser, D. W. 1961. Effectiveness of lipid and lipidophilic substances as adjuvants. Nature 191:1169.
2. Waksman, B. H. 1979. Adjuvants and immune regulation by lymphoid cells. Springer Semin. Immunopathol. 2:5.
3. Elson, C. O. 1996. Cholera toxin as a mucosal adjuvant. In Mucosal Vaccines. H. Kiyono, P. L. Ogra, and J. R. McGhee, eds. Academic Press, San Diego, p. 59.
4. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736.
5. Pierce, N. F., and W. C. Cray. 1982. Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats. J. Immunol. 128:1311.
6. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:2892.
7. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
8. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301.
9. Hornquist, E., and N. Lycke. 1993. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 23:2136.
10. Snider, D. P., J. S. Marshall, M. H. Perdue, and H. Liang. 1994. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153:647.
11. McGee, D. W., C. O. Elson, and J. R. McGhee. 1993. Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines. Infect. Immun. 61:4637.
12. Bromander, A., J. Holmgren, and N. Lycke. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908.
13. Unanue, E. R., and P. M. Allen. 1987. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
15. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natt. Acad. Sci. USA 87:5031.
16. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
17. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
18. Reiser, H., G. J. Freeman, Z. Razi-Wolf, C. D. Gimmi, B. Benacerraf, and L. M. Nadler. 1992. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl. Acad. Sci. USA 89:271.
19. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, Jr., L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation [see comments]. Science 262:909.
20. Bucy, R. P., A. Panoskaltsis-Mortari, G. Huang, J. Li, L. Karr, M. Ross, J. H. Russell, K. M. Murphy, and C. T. Weaver. 1994. Heterogeneity of single cell cytokine gene expression in cloned T cell populations. J. Exp. Med. 180: 1251.
21. Doherty, T. M., and R. L. Coffman. 1993. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 150:5476.
22. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus derived lymphocytes. Eur. J. Immunol. 3:645.
23. Buelens, C., F. Willems, A. Delvaux, G. Peirard, J.-P. Delville, T. Velu, and M. Goldman. 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25:2668.
24. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J. Immunol. 151:1224.
25. + T cells that secrete IFN-γ and IL-5. J. Immunol. 145:68.
26. Dertzbaugh, M. T., and C. O. Elson. 1993. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 61:48.
27. Russell, M. W., T. A. Brown, J. Radl, J. J. Haajman, and J. Mestecky. 1986. Assay of human subclass antibodies in serum and secretions by means of monoclonal antibodies. J. Immunol. Methods 87:87.
28. Rodbard, D., and D. M. Hutt. 1974. Statistical analysis of radioimmunoassays and immunoradiometric (labelled antibody) assays: a generalized, weighted, iterative, least-squares method for logistic curve fitting. In Symposium on Radioimmunoassay and Related Procedures in Clinical Medicine. International Atomic Energy Agency, Vienna, p. 165.
29. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
30. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
31. DeBenedette, M. A., N. R. Chu, K. E. Pollok, J. Hurtado, W. F. Wade, B. S. Kwon, and T. H. Watts. 1995. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med. 81:985.
32. Moss, J., and M. Vaughan. 1988. ADP-ribosylation of guanyl nucleotide-binding proteins by bacterial toxins. Adv. Enzymol. 61:303.
33. Elson, C. O., S. P. Holland, M. T. Dertzbaugh, C. F. Cuff, and A. O. Anderson. 1995. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 154:1032.
34. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, Jr., L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
35. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X. Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
36. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979.
37. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621.
38. Jackson, R. J., H. F. Staats, J. Xu-Amano, I. Takahashi, H. Kiyono, M. E. Hudson, R. M. Gilley, S. N. Chatfield, and J. R. McGhee. 1994. Oral vaccine models: multiple delivery systems employing tetanus toxoid. Ann. NY Acad. Sci. 730:217.
39. Finkelman, F. D., E. M. Katona, T. R. Mosmann, and R. L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022.
40. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9:222.
41. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Escherichia call heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277.
42. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617.
43. Jansen, E., T. A. Ayoubi, S. M. Meulemans, and W. J. Van de Ven. 1995. Neuroendocrine-specific expression of human prohormone convertase 1 gene: hormonal regulation of transcription through distinct cAMP response elements. J. Biol. Chem. 270:15391.
44. Desdouets, C., G. Matesic, C. A. Molina, N. S. Foulkee, P. Sassone-Corsi, C. Brechot, and J. Sobczak-Thepot. 1995. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol. Cell. Biol. 15:3301.